Can we do more to risk stratify and improve survival in ACHD?

Affiliations

¹ Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, St Vincent's Hospital Melbourne, Australia. Electronic address: t.roberts2@rbht.nhs.uk.
² Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, United Kingdom; National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom.

Editorial

Timothy J Roberts et al. Int J Cardiol. 2017.

. 2017 Oct 15:245:147-148.

doi: 10.1016/j.ijcard.2017.07.059.

¹ Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, St Vincent's Hospital Melbourne, Australia. Electronic address: t.roberts2@rbht.nhs.uk.
² Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, United Kingdom; National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom.

No abstract available

Comment on

Mortality in adults with congenital heart disease.
Naidu P, Grigg L, Zentner D. Naidu P, et al. Int J Cardiol. 2017 Oct 15;245:125-130. doi: 10.1016/j.ijcard.2017.05.132. Int J Cardiol. 2017. PMID: 28874283